| Long-term Safety and Tolerability of HSK39297 in Patients With Paroxysmal Nocturnal Hemoglobinuria (NCT06745622) | Haisco Pharmaceutical Group Co., Ltd. | 2025-01-03 |
| A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (NCT06588478) | Loxo Oncology, Inc. | 2025-01-03 |
| Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment of Newly Diagnosed Monocytic AML and Active Signaling Mutated AML (NCT06504459) | OHSU Knight Cancer Institute | 2025-01-03 |
| The Impact of Metastatic Directed Radiotherapy (MDRT) on Oligoprogressive Castration Resistant Prostate Cancer (CRPC) (NCT07038304) | University Medical Center Groningen | 2025-01-03 |
| GRAViceptive NEGlect Treatment in Acute Stroke Using Targeted Cranial ELECTrotherapy (NCT06747676) | University of Sao Paulo | 2025-01-03 |
| Pharmacokinetics and Safety of Givinostat in DMD Patients Ages From at Least 2 Years to Less Then 6 Years Old (NCT06769633) | Italfarmaco | 2025-01-02 |
| Telehealth Intervention for Ostomy Self-Management (NCT06528990) | City of Hope Medical Center | 2025-01-02 |
| Efficacy of Short-course Blinatumomab for MRD Erradication in B-ALL (NCT06886074) | Hospital Universitario Dr. Jose E. Gonzalez | 2025-01-02 |
| Evaluate Safety and Pharmacokinetics of INF904 in Subjects With Moderate to Severe Chronic Spontaneous Urticaria or Hidradenitis Suppurativa (NCT06555328) | InflaRx GmbH | 2025-01-02 |
| Patient Priorities for Survivorship Care in Older Breast Cancer Survivors (NCT06478589) | The University of Texas Health Science Center, Houston | 2025-01-02 |
| RCT of Efficacy and Safety of CP003 on CFS/ME or Post-COVID Fatigue (NCT06739720) | The University of Hong Kong | 2025-01-02 |
| RAPA-501 Therapy for ALS (NCT04220190) | Rapa Therapeutics LLC | 2025-01-02 |
| A Clinical Trial to Compare Efficacy and Tolerability of Atorvastatin in Addition to Endocrine Treatment With Focus on Mechanisms of Resistance to Endocrine Treatment (Fulvestrant/Aromatase Inhibitors) in Patients With Advanced Breast Cancer (NCT02958852) | Lund University Hospital | 2025-01-02 |
| Efficacy of Low-dose Venetoclax With Itraconazole + TACL for R/R ALL Patients (NCT07039877) | Hospital Universitario Dr. Jose E. Gonzalez | 2025-01-02 |
| Study of TPEx Followed by a Maintenance With Avelumab and Cetuximab in First Line Recurrent or Metastatic Squamous Cell Carcinoma of the H&N (NCT06640725) | Groupe Oncologie Radiotherapie Tete et Cou | 2025-01-02 |
| A Dose-Image Optimization Trial Evaluating Mannitol and Voluven as Adjuncts for Indocyanine Green (NCT06768268) | National Taiwan University Hospital | 2025-01-01 |
| Perioperative Toripalimab and Endostatin for Stage II Melanoma: A Phase II Trial (NCT06965231) | Fudan University | 2025-01-01 |
| Various Procedural Treatment Options for Post-acne Atrophic Scars (NCT06770608) | Sheikh Zayed Medical College | 2025-01-01 |
| Female Sexual Dysfunction Assessment and Managment of Vaginismus (NCT06755099) | Assiut University | 2025-01-01 |
| Phase II Study of RP2 as Immunoprevention in High-Risk Oral Precancerous Disease (NCT06623110) | Glenn J. Hanna | 2025-01-01 |
| Stereotactic Body Radiation Therapy for Unresectable Locally Recurrent Rectal Cancer (NCT07297004) | Sixth Affiliated Hospital, Sun Yat-sen University | 2025-01-01 |
| Clinical and Radiographic Evaluation of Allogenic Dentin Grafts for Alveolar Ridge Preservation (NCT06827665) | Jordan University Hospital | 2025-01-01 |
| Tranilast Vs. Steroids to Prevent Esophageal Stricture (TAPES) After Endoscopic Resection for Superficial Neoplasms (NCT06643689) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2025-01-01 |
| Herbal Evaluation Of Artemisia Annua For Small Intestinal Bacterial Overgrowth (NCT06721884) | National University of Natural Medicine | 2025-01-01 |
| Multi-cohort, Single-arm, Phase II Study of the Efficacy and Side Effects of Cisplatin Plus Gemcitabine in the Treatment of PD1 Failure or Intensive Treatment of Some Rare Tumors (NCT07046650) | Sheng Zhang | 2025-01-01 |
| Clinical Trial of Gammora® Plus Antiretroviral Treatment for HIV (NCT06799650) | Federal University of São Paulo | 2025-01-01 |
| SIL as Maintenance Therapy in Multiple Myeloma (NCT06744894) | Navy General Hospital, Beijing | 2025-01-01 |
| Low-dose Selumetinib for the Treatment of Plexiform Neurofibromas in Chinese Children (NCT06763315) | West China Hospital | 2025-01-01 |
| Evaluation of the Safety and Efficacy of Parecoxib in Patients With Subarachnoid Hemorrhage (NCT06579274) | St. Anne's University Hospital Brno, Czech Republic | 2025-01-01 |
| Probiotics in Advanced Urothelial Carcinoma (NCT06904573) | Sun Yat-sen University | 2025-01-01 |
| A Study Evaluating the Efficacy and Safety of De Trastuzumab (T-DXd) in Combination with Immunotherapy for the Neoadjuvant Treatment of HR-positive HER2 Low-expressing Chinese Patients with Early-stage Breast Cancer (NCT06733233) | Guangzhou Women and Children's Medical Center | 2025-01-01 |
| Open-label, Single-arm, Proof of Concept Study in Subjects with Mild-to-moderate Facial Hyperpigmentation (NCT06473974) | Kayuraeffect, LLP | 2025-01-01 |
| Efficacy of Tranexamic Acid Reducing Blood Loss During Maxillofacial Trauma Surgery (NCT07392034) | Nishtar Medical University | 2025-01-01 |
| CBD Delivery with the A-Synaptic GT4 Transdermal Delivery System in with Dravet Syndrome And/or Lennox-Gastaut Syndrome (NCT06738732) | Alexander Rotenberg | 2025-01-01 |
| Supplementation for Male Subfertility (NCT06091969) | Hamilton Health Sciences Corporation | 2025-01-01 |
| Zanubrutinib Combined With G-CVP in Previously Untreated FL (NCT06959732) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2025-01-01 |
| The Effect of ROCK Inhibitors on Corneas of Patients With Glaucoma and Pseudophakic Bullous Keratopathy (PBK) (NCT06960629) | University Hospital Dubrava | 2025-01-01 |
| Fiber and Calcium Absorption in Older Men (NCT06519877) | VA Office of Research and Development | 2025-01-01 |
| Enhanced Adjuvant Therapy for Newly Diagnosed GBM With Partial Surgical Resection or Short-term Progression (NCT06936046) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2025-01-01 |
| Medical Herbs Inhibit Inflammation Directing T Cells to Kill the COVID-19 Virus (COVID) (NCT04790240) | All Natural Medicine Clinic, LLC | 2025-01-01 |
| Sensor-based Just-in Time Adaptive Interventions (JITAIs) Targeting Eating Behavior (NCT06547320) | The Miriam Hospital | 2025-01-01 |
| RT for Adenocarcinoma/Adenosquamous Carcinoma (NCT07153952) | Peking Union Medical College Hospital | 2025-01-01 |
| Phase 1b/2a in SLE With Budoputug (NCT06570434) | Tenet Medicines | 2025-01-01 |
| Anti-BTLA Agonist Therapy in Subjects With Primary Sjogren's Syndrome (NCT05781451) | Stanford University | 2025-01-01 |
| 18F-mFBG Expression in Neural Crest Tumors and Organs Innervated by the Sympathetic Nervous System (NCT06233903) | Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC) | 2025-01-01 |
| Study of Precision Treatment for Rare Tumours in China Guided by PDO and NGS (NCT06692491) | Peking University Shenzhen Hospital | 2025-01-01 |
| Effort and Antidepressant Study Test (NCT06696482) | University of Oxford | 2025-01-01 |
| Proprioceptive Neuromuscular Facilitation vs Conventional Therapy With Ultrasound-Guided Corticosteroid Injections for Subacromial Bursitis (NCT07508969) | University of Catanzaro | 2025-01-01 |
| Selinexor Combined With Venetoclax Maintenance Therapy After Allo-HSCT (NCT06765928) | Ruijin Hospital | 2025-01-01 |
| Efbemalenograstim Alfa for Primary/Secondary Prevention in Patients With Solid Tumors at High Risk for Febrile Neutropenia (FN) or Intermediate Risk of Chemotherapy Regimens Associated With Other Risk Factors in FN (NCT07187908) | Henan Cancer Hospital | 2025-01-01 |
| Delayed Supine Position Post-Spinal Compared With Immediate Supine Position in Geriatric Patients (NCT07520695) | Sohar Hospital | 2025-01-01 |
| A Study to Evaluate the Safety, Tolerability and Efficacy in Patients With Burn(s) (NCT06440239) | Primoris Therapeutics | 2025-01-01 |
| Effect of Nutritional Management on Patients With Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma (NCT07085988) | Jiangxi Provincial Cancer Hospital | 2025-01-01 |
| Phase II Study of Adebrelimab, Chemotherapy, and Apatinib for Advanced Pulmonary Neuroendocrine Tumors (NCT06764368) | Beijing Chest Hospital | 2025-01-01 |
| Preoperative Partial Breast Reirradiation and Repeat Breast-conserving Surgery in Patients With Recurrent Breast Cancer: the REPEAT Trial (NCT06640881) | Amsterdam UMC, location VUmc | 2025-01-01 |
| Tenapanor in Synucleinopathy-Related Constipation (NCT06460038) | Cedar Valley Digestive Health Center | 2025-01-01 |
| Efficacy and Safety of Finerenone and Empagliflozin in Delaying Renal Function Progression After Radical Nephrectomy in High-Risk CKD Patients: A Multicenter RCT (NCT06818305) | Jinling Hospital, China | 2025-01-01 |
| Doxecitin and Doxribthymine in Adult Subjects With Thymidine Kinase 2 (TK2) Deficiency (NCT06754098) | Cristina Domínguez González | 2025-01-01 |
| A Single-arm, Open-label, Prospective Clinical Study of Surufatinib Combined With Immunotherapy and Chemotherapy for Unresectable or Metastatic Biliary Tract Cancer. (NCT06654947) | Fujian Cancer Hospital | 2025-01-01 |
| Dual-target iTBS for Youth With ADHD (NCT07084649) | Shanghai Mental Health Center | 2025-01-01 |
| Study Evaluating Pembrolizumab +/- Olaparib in TLS Positive Selected Resectable STS Followed by Adjuvant Pembrolizumab (NCT06116578) | Gustave Roussy, Cancer Campus, Grand Paris | 2025-01-01 |
| Pioglitazone-Metformin Combination Treatment for High Risk Oral Preneoplasia (NCT05727761) | University of Minnesota | 2025-01-01 |
| Botanical Tincture for Symptoms of Irritable Bowel Syndrome (NCT03923322) | Stamford Hospital | 2025-01-01 |
| A Study of Human Allogeneic Bone-marrow-derived Mesenchymal Stromal Cell Product (StromaForte) in Patients With Aging Frailty (NCT06070532) | Cellcolabs Clinical LTD. | 2025-01-01 |
| SBRT Combined With Adbelimumab and Apatinib for Perioperative and Conversion Therapy of Hepatocellular Carcinoma (NCT06538935) | Fujian Cancer Hospital | 2025-01-01 |
| Phase II Clinical Trial of De-Intensified Therapy in Human Papilloma Virus (HPV) Associated Oropharyngeal Squamous Cell Carcinoma (NCT06759155) | University of Vermont Medical Center | 2025-01-01 |
| Psychedelic-assisted Group Program for First Responders (NCT06471959) | Empower Research Inc | 2025-01-01 |
| FOLFOX Plus Lenvatinib Adjuvant Therapy for Hepatocellular Carcinoma Post-Liver Transplantation (NCT06409637) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2025-01-01 |
| HAIC Combined with Donafenib and Sintilimab As Perioperative Treatment for Resectable Hepatocellular Carcinoma Patients At High Risk of Recurrence (NCT06812039) | Fudan University | 2025-01-01 |
| Preoperative Chemoradiotherapy and Toripalimab in Locally Recurrent Rectal Cancer (NCT06751394) | Sixth Affiliated Hospital, Sun Yat-sen University | 2025-01-01 |
| Osimertinib Combined With Savolitinib in the Treatment of NSCLC With Low Copy Number MET Amplification (NCT07322783) | Qingdao Central Hospital | 2025-01-01 |
| A Study of CGRP Monoclonal Antibody to Treat Diabetic Neuropathy (NCT05937152) | Mayo Clinic | 2025-01-01 |
| Apply the PD Model of Peripheral Oxytocin Action to a Multimodal Stimulus (NCT04433741) | Wake Forest University Health Sciences | 2025-01-01 |
| A Study of RC48-ADC Combined With JS001 for Advanced Extramammary Paget Disease of the Scrotum (NCT06791070) | Fujian Medical University Union Hospital | 2025-01-01 |
| Anti-CD 19 CAR-T Cell Therapy in Patients With ANCA Vasculitis (NCT06590545) | David Simon | 2025-01-01 |
| Prospective Study on Exemption of Tumor Bed Boost Radiotherapy for pCR Patients After Breast Conserving Surgery With Neoadjuvant Therapy (NCT07113613) | The First Affiliated Hospital with Nanjing Medical University | 2025-01-01 |
| Sirolimus Treatment Of Patients With SLE (NCT04736953) | State University of New York - Upstate Medical University | 2025-01-01 |
| Surgery and Reducing Ionizing Radiation of the Unknown Primary (NCT06578871) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2025-01-01 |
| Autologous BMA vs Saline and LAM + LP-PRP vs Saline Evaluations in Knee OA (NCT05517434) | University Health Network, Toronto | 2025-01-01 |
| The NADage Study: Nicotinamide Riboside Replenishment Therapy Against Functional Decline in Aging (NCT06208527) | Haukeland University Hospital | 2025-01-01 |
| Toripalimab Combined With Chemotherapy as Adjuvant Therapy for Non-small Cell Lung Cancer With or Without Prior Neoadjuvant Therapy (NCT07039656) | Wen-zhao ZHONG | 2025-01-01 |
| Evaluation of the Cardioprotective Effect of Nebivolol on Trastuzumab-Induced Cardiotoxicity in Breast Cancer Patients (NCT07233499) | Ain Shams University | 2025-01-01 |
| Neoadjuvant Study of HIFU With or Without PD-1 Inhibitors Followed by Abraxane Plus Carboplatin in Triple-Negative Breast Cancer. (NCT07394387) | The First Affiliated Hospital with Nanjing Medical University | 2025-01-01 |
| Prophylactic IV Paracetamol in Extremely Premature Infants (NCT07067177) | Al-Quds University | 2025-01-01 |
| Role of Ondansetron in Spinal Anaesthesia Induced Hypotension (NCT06727201) | Assiut University | 2025-01-01 |
| Baricitinib in CPPD - the BAPTIST Study (NCT06768294) | I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio | 2025-01-01 |
| Efficacy and Safety of CD19/CD20 CAR/TRuC-T in Relapsed/Refractory B-Cell Lymphoma (NCT07508605) | Shenzhen University General Hospital | 2025-01-01 |
| Pembrolizumab and Pemetrexed for Progressive Chordoma (NCT06794645) | Saint John's Cancer Institute | 2025-01-01 |
| Intravenous Hydromorphone for the Treatment of Acute Pain (NCT06949059) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2025-01-01 |
| Oxytocin Pharmacokinetics and Pharmacodynamics (NCT05488457) | Stanford University | 2025-01-01 |
| Validate a Pharmacodynamic Model of Oxytocin for Peripheral Analgesic Effects (NCT04435704) | Wake Forest University Health Sciences | 2025-01-01 |
| Baricitinib for Patients With Intracerebral Hemorrhage (NCT06737705) | De-zhi Kang | 2025-01-01 |
| MLC1501 Study Assessing Efficacy in STROke Recovery (NCT05046106) | Moleac Pte Ltd. | 2025-01-01 |
| Ambroxol as a Novel Disease Modifying Treatment for Lewy Body Dementia (NCT04405596) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2025-01-01 |
| SBRT Combined with Camrelizumab and Apatinib for Conversion Therapy in Patients with Unresectable Hepatocellular Carcinoma. (NCT06739317) | Sun Yat-sen University | 2025-01-01 |
| Irinotecan Liposome (II) or Etoposide Combined With Adebrelimab and Carboplatin in the Treatment of ES-SCLC (NCT06739928) | Guangzhou Institute of Respiratory Disease | 2025-01-01 |
| High-dose Methotrexate Combined with Thiotepa and Zanubrutinib in the Treatment of Newly Diagnosed PCNSL (MTZ) (NCT06646211) | Sun Yat-sen University | 2025-01-01 |
| Human Umbilical Cord Mesenchymal Stem Cells for Alport Syndrome (NCT06731192) | Guangzhou Women and Children's Medical Center | 2025-01-01 |
| Post-surgical Outcomes With Anabolic Agent Use in High-risk Ankle Fractures: A Pilot RCT (NCT06303284) | University of Calgary | 2025-01-01 |
| A Clinical Trial to Evaluate Effect of IAE0972 Combined with Chemotherapy for R/M HNSCC or NPC(Note: It is Currently Phase II.). (NCT06719479) | SUNHO（China）BioPharmaceutical CO., Ltd. | 2025-01-01 |